Endothelial Glycocalyx Disintegrity: Repairing the Damage caused by Trauma-Hemorrhage
内皮糖萼破坏:修复创伤出血造成的损伤
基本信息
- 批准号:10027428
- 负责人:
- 金额:$ 34.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AreaAttenuatedBasic ScienceCause of DeathCell surfaceCessation of lifeEndothelial CellsEndotheliumFailureFunctional disorderGlycocalyxGlycosaminoglycansGoalsHemorrhageHemorrhagic ShockHeparitin SulfateHyaluronic AcidInflammationInjuryIntestinesKidneyLungMediatingMicrovascular DysfunctionMicrovascular PermeabilityOrganPatientsPermeabilityResearchResuscitationRoleSecondary toSignal PathwayTraumaTraumatic injurybody systemheparanaseinnovationmortalitynew therapeutic targetorgan injurypreventprogramsrepairedresponsetranslational research programtranslational study
项目摘要
PROJECT SUMMARY/ABSTRACT
The aim of this R35 application is to develop a high quality, translational research program in inflammation-
induced endothelial damage and organ dysfunction. Dysregulation of microvascular function contributes to the
pathophysiology of indirect organ injury after trauma. In particular, damage to the endothelial glycocalyx occurs
within minutes of traumatic injury and is associated with increased microvascular permeability resulting in multi-
organ failure and increased mortality. Strategies that attenuate glycocalyx disintegrity by preventing its cleavage
and/or facilitating its repair hold significant promise for minimizing microvascular dysfunction and post-traumatic
organ injury. The long-term objective of our research program is to establish basic science and translational
studies that focus on the identification of novel therapeutic targets that will (1) prevent glycocalyx damage, (2)
repair glycocalyx integrity or (3) inhibit dysregulation of endothelial cell permeability that occurs as a result of
glycocalyx disintegrity. The specific programmatic areas of focus will include studies to identify the role of
heparanase in regulating glycocalyx (dis)integrity after trauma-hemorrhage and on mechanisms that mediate
glycocalyx synthesis. Additionally, our proposed studies will identify signaling pathways that regulate endothelial
barrier function that are effected by loss of cell surface glycosaminoglycans, heparan sulfate and hyaluronic acid,
which are primary constituents of the glycocalyx layer. Our research program will focus on the endothelial cell-
specific response to trauma-hemorrhage in organ systems that are most susceptible to secondary injury (e.g.,
kidney, lung and intestines) with the over-arching goal of determining how resuscitation strategies mediate
glycocalyx-dependent mechanisms in each organ. These programmatic areas of research hold promise for
significantly impacting the current resuscitation paradigm for patients in hemorrhagic shock by aiding in the
discovery of novel therapeutic targets that can be used to inhibit glycocalyx dysfunction, facilitate its repair or
reverse the downstream consequences of glycocalyx disintegrity.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jillian Rouse Richter其他文献
Jillian Rouse Richter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jillian Rouse Richter', 18)}}的其他基金
Live Cell Confocal Microscopy for Real-Time Imaging of Endothelial Glycocalyx Damage and Repair
活细胞共聚焦显微镜用于内皮糖萼损伤和修复的实时成像
- 批准号:
10797987 - 财政年份:2020
- 资助金额:
$ 34.01万 - 项目类别:
Endothelial Glycocalyx Disintegrity: Repairing the Damage caused by Trauma-Hemorrhage
内皮糖萼破坏:修复创伤出血造成的损伤
- 批准号:
10248473 - 财政年份:2020
- 资助金额:
$ 34.01万 - 项目类别:
Endothelial Glycocalyx Disintegrity: Repairing the Damage caused by Trauma-Hemorrhage
内皮糖萼破坏:修复创伤出血造成的损伤
- 批准号:
10645012 - 财政年份:2020
- 资助金额:
$ 34.01万 - 项目类别:
Endothelial Glycocalyx Disintegrity: Repairing the Damage caused by Trauma-Hemorrhage
内皮糖萼破坏:修复创伤出血造成的损伤
- 批准号:
10430244 - 财政年份:2020
- 资助金额:
$ 34.01万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 34.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 34.01万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 34.01万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 34.01万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 34.01万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 34.01万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 34.01万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 34.01万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 34.01万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 34.01万 - 项目类别:
Idea to Innovation